0001144204-16-077036.txt : 20160126 0001144204-16-077036.hdr.sgml : 20160126 20160126171202 ACCESSION NUMBER: 0001144204-16-077036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160126 FILED AS OF DATE: 20160126 DATE AS OF CHANGE: 20160126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001208261 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 940 CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-440-9310 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 940 CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: EPICEPT CORP DATE OF NAME CHANGE: 20021129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Teper Daniel Gedeon CENTRAL INDEX KEY: 0001584822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36602 FILM NUMBER: 161362357 MAIL ADDRESS: STREET 1: C/O IMMUNE PHARMACEUTICALS INC. STREET 2: 777 OLD SAW MILL RIVER RD. CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 v429748_form4.xml FORM 4 X0306 4 2016-01-26 0 0001208261 IMMUNE PHARMACEUTICALS INC IMNP 0001584822 Teper Daniel Gedeon C/O IMMUNE PHARMACEUTICALS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 1 1 1 0 CEO Common Stock 2016-01-26 4 P 0 42000 0.5911 A 4810905 D The transaction reported in this line item was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2015. /s/ Daniel G. Teper 2016-01-26